NR4A agonist-2
NR4A agonist-2 is a selective pan-NR4A agonist designed based on Vidofludimus (HY-14908), with a Kd of 0.10 μM against NR4A1, and EC50 values of 0.098 μM, 0.092 μM and 0.09 μM against Nur77, Nurr1, NOR-1, respectively. NR4A agonist-2 exhibits 47-fold selectivity over DHODH, and shows no cytotoxic activity at concentrations up to 10 μM. By binding to a specific surface pocket in the ligand-binding domain of Nurr1, NR4A agonist-2 inhibits the formation of Nurr1 homodimers, activates response elements such as NBRE, NurRE, DR5, and then potently induces the expression of neuroprotective genes including BDNF, SOD2, thereby exerting neuroprotective activity. NR4A agonist-2 can be used in the research of neurodegenerative diseases such as Parkinson's disease, dementia and multiple sclerosis.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C20H14ClF2NO5
- 분자량:421.78
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Nuclear Hormone Receptor 4A/NR4A Isoforms
More
Biological Activity
제품 설명
IC50 & Target
|
Nur77/NR4A1 0.098 μM (EC50) |
Nurr1/NR4A2 0.092 μM (EC50) |
In Vitro
NR4A agonist-2 (compound 53) (0.3-1 μM; 20 h) dose-dependently induces the mRNA expression of neuroprotective genes including BDNF, FLRT2 and SOD2 in qPCR assays using N27 rat dopaminergic neurons[1].
NR4A agonist-2 (10 μM; 2 h) significantly inhibits the formation of Nurr1 ligand-binding domain homodimers in HTRF assays, with an inhibition rate of approximately 9-fold[1].
In various toxicity assays of HEK293T cells treated with NR4A agonist-2 (0.1-10 μM; 24 h), the compound exerts no significant effects on cell confluency and metabolic activity, nor does it induce cell necrosis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK293T
-
Concentration:0.1 μM, 1 μM, 10 μM
-
Incubation Time:24 h
-
Result:Did not significantly affect cell confluence, metabolic activity, or induce necrosis in HEK293T cells, showing no obvious cytotoxicity at all tested concentrations.
-
Cell Line:N27 rat dopaminergic neurons
-
Concentration:0.3 μM, 0.6 μM, 1 μM
-
Incubation Time:20 h
-
Result:Dose-dependently induced the mRNA expression of neuroprotective genes including BDNF, FLRT2, NRP-1, CRMP4, Sesn3, CCND2, XIAP, and SOD2, with more potent effects than Vidofludimus (HY-14908) at 1 μM.
Chemical Information
-
분자량 421.78
-
화학식 C20H14ClF2NO5
-
SMILES
O=C(NC1=C(C=C(C=C1)C2=C3C(OC(F)(O3)F)=CC=C2)Cl)C4=C(CCC4)C(O)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Human pluripotent stem cell midbrain dopaminergic neuron differentiation
Human pluripotent stem cells are directed toward midbrain dopaminergic neurons by first inducing a neural floor-plate-like progenitor state, then patterning cells with ventralizing SHH signaling and midbrain/WNT-FGF cues, and finally maturing progenitors into neurons expressing dopaminergic markers such as TH, NURR1/NR4A2, PITX3, DAT/SLC6A3, VMAT2/SLC18A2, GIRK2/KCNJ6, FOXA2, LMX1A, and EN1. The main readouts are loss of pluripotency, acquisition of FOXA2+/LMX1A+ midbrain floor-plate progenitors, emergence of βIII-tubulin+/MAP2+ neurons, and production of TH+ dopaminergic neurons with molecular, dopamine-release, and electrophysiological features of midbrain dopaminergic identity.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)